Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Completed

• Conditions: Myopia
• Interventions: Drug: Bromfenac

• Registration Number: NCT01475877
• Lead Sponsor: Virdi Eye Clinic

Brief Summary

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05
• Study First Submitted: 2011-11-07
• Study First Submitted QC: 2011-11-16
• Study First Posted: 2011-11-21
• Primary Completion: 2012-05
• Study Completion: 2012-05
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-01
• Last Update Posted: 2016-05-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• male or female at least 18 years of age,
• no other ocular studies with 15 days prior to dosing,
• BCVA 20/200 or better,
• return for study visits and follow instructions from investigator and staff,
• self administer test article

Exclusion Criteria

• Ocular inflammation,
• hypersensitivity to bromfenac or nepafenac,
• any corneal pathology,
• have had radial keratotomy,
• corneal transplant or corneal refractive surgery in the last two years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Nepafenac	Bromfenac	-

Primary Outcome Measures

Name	Time	Method
Post-PRK pain	7 days

Secondary Outcome Measures

Name	Time	Method
Post-PRK epithelial healing	7 days

Trial Locations

Locations (1)

Virdi Eye Clinic and Laser Vision Center; 🇺🇸 Rock Island, Illinois, United States